News and Analysis

Walking Fish Therapeutics picks up $50m Series A

Walking Fish Therapeutics, a B cell engineering company, has raised $50 million in Series A financing.

-

Walking Fish Therapeutics, a B cell engineering company, has raised $50 million in Series A financing. The investors included Emerson Collective, Illumina Ventures and Quan Capital.

Source: Press Release